Healthcare
Adora Health
Recorded May 6, 2025
Adora Life Science is unlocking the potential of a drug that stimulates cartilage repair and can slow the progression of degenerative joint disease.
Adora Life Science is unlocking the potential of a drug that stimulates cartilage repair and can slow the progression of degenerative joint disease.
NeuroVision’s AI-driven BrainHealth Platform is redefining how we prevent, diagnose, and treat Alzheimer’s and other neurological conditions
Sigyn Therapeutics [OTCQB: SIGY] is a pioneering developer of medical devices targeting cancer, infectious diseases, and more
Sigyn Therapeutics [OTCQB: SIGY] is a pioneering developer of medical devices targeting cancer, infectious diseases, and more
Cellibre has developed a platform technology to produce chemicals creating less expensive, higher quality, and more resilient supply chains.
Cellibre has developed a platform technology to produce chemicals creating less expensive, higher quality, and more resilient supply chains.
The company’s AI-powered drug development program has the potential to uncover treatments for multiple diseases and impact millions of lives.
The company’s AI-powered drug development program has the potential to uncover treatments for multiple diseases and impact millions of lives.
Nordicus has successively completed its first toxicity study for Orocidin QR-01, a novel treatment for aggressive periodontitis.
Nordicus has successively completed its first toxicity study for Orocidin QR-01, a novel treatment for aggressive periodontitis.
An innovative, clinical stage, drug development company that is creating a potential novel treatment for degenerative eye disease
An innovative, clinical stage, drug development company that is creating a potential novel treatment for degenerative eye disease
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2025 FORCE Family Office
